Maxion Therapeutics: Funding, Investors & Team (Aug 2026)
Maxion creates therapeutic candidates against ion channels and GPCR proteins by combining its novel KnotBody technology with in vitro display technologies.
Maxion Therapeutics has raised $15.6M across 1 funding round on record, the most recent a Series A of $15.6M announced in Feb 2023.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Maxion Therapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Maxion Therapeutics Funding Rounds
Maxion Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Maxion Therapeutics Funding Compared to Other Health Care Startups
Maxion Therapeutics' latest round of $15.6M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Maxion Therapeutics in Health Care and Cambridge
Companies Similar to Maxion Therapeutics
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Asterix Health is the workforce solution for modern healthcare.
Gloucester Rugby is a professional English rugby union club that gives up to date with all the information…
Maxion Therapeutics Funding FAQs
What does Maxion Therapeutics do?
Maxion creates therapeutic candidates against ion channels and GPCR proteins by combining its novel KnotBody technology with in vitro display technologies.
How much funding has Maxion Therapeutics raised?
Maxion Therapeutics has raised $15.6M across 1 round on record. The most recent is a Series A of $15.6M announced in Feb 2023.
When did Maxion Therapeutics last raise funding?
Maxion Therapeutics' most recent funding round on record is a Series A of $15.6M, announced in Feb 2023.
Who is the CEO of Maxion Therapeutics?
John Mccafferty is listed as CEO at Maxion Therapeutics.
Where is Maxion Therapeutics headquartered?
Maxion Therapeutics is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Maxion Therapeutics have?
Maxion Therapeutics is in the 1-10 employee band.
How does Maxion Therapeutics' funding compare to other Health Care startups?
Maxion Therapeutics' latest round of $15.6M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Maxion Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Maxion Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.